Cite

[Recommendations for the cytogenetic management of chronic myeloid leukemia (CML) proposed by the French Group for Cytogenetic Hematology].

MLA

Dastague, N. “[Recommendations for the Cytogenetic Management of Chronic Myeloid Leukemia (CML) Proposed by the French Group for Cytogenetic Hematology].” Pathologie-Biologie, vol. 52, no. 5, June 2004, pp. 238–40. EBSCOhost, https://doi.org/10.1016/j.patbio.2004.04.004.



APA

Dastague, N. (2004). [Recommendations for the cytogenetic management of chronic myeloid leukemia (CML) proposed by the French Group for Cytogenetic Hematology]. Pathologie-Biologie, 52(5), 238–240. https://doi.org/10.1016/j.patbio.2004.04.004



Chicago

Dastague, N. 2004. “[Recommendations for the Cytogenetic Management of Chronic Myeloid Leukemia (CML) Proposed by the French Group for Cytogenetic Hematology].” Pathologie-Biologie 52 (5): 238–40. doi:10.1016/j.patbio.2004.04.004.